The stock of Hologic, Inc (HOLX) has gone up by 1.40% for the week, with a 16.40% rise in the past month and a 1.19% rise in the past quarter. The volatility ratio for the week is 1.35%, and the volatility levels for the past 30 days are 3.60% for HOLX. The simple moving average for the last 20 days is 8.90% for HOLX stock, with a simple moving average of -10.74% for the last 200 days.
Is It Worth Investing in Hologic, Inc (NASDAQ: HOLX) Right Now?
The price-to-earnings ratio for Hologic, Inc (NASDAQ: HOLX) is above average at 26.62x. The 36-month beta value for HOLX is also noteworthy at 0.55. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 4 rating it as “overweight,” 13 rating it as “hold,” and 0 rating it as “sell.”
The public float for HOLX is 220.84M, and at present, short sellers hold a 3.29% of that float. The average trading volume of HOLX on June 04, 2025 was 3.61M shares.
HOLX) stock’s latest price update
The stock of Hologic, Inc (NASDAQ: HOLX) has increased by 1.66 when compared to last closing price of 62.01. Despite this, the company has experienced a 1.40% gain in its stock price over the last five trading sessions. businesswire.com reported 2025-06-02 that ARLINGTON, Va.–(BUSINESS WIRE)–NEST, an initiative of MDIC, is pleased to welcome Hologic, a leading global medical device company, to its Governance Committee.
Analysts’ Opinion of HOLX
Leerink Partners gave a rating of “Market Perform” to HOLX, setting the target price at $75 in the report published on February 06th of the current year.
HOLX Trading at 7.76% from the 50-Day Moving Average
After a stumble in the market that brought HOLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.55% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HOLX starting from Madaus Martin D, who purchase 5,445 shares at the price of $55.24 back on May 07 ’25. After this action, Madaus Martin D now owns 5,445 shares of Hologic, Inc, valued at $300,760 using the latest closing price.
Mitchell Essex D, the Chief Operating Officer of Hologic, Inc, sale 24,856 shares at $76.34 during a trade that took place back on Dec 04 ’24, which means that Mitchell Essex D is holding 27,957 shares at $1,897,482 based on the most recent closing price.
Stock Fundamentals for HOLX
Current profitability levels for the company are sitting at:
- 0.18 for the present operating margin
- 0.52 for the gross margin
The net margin for Hologic, Inc stands at 0.14. The total capital return value is set at 0.09. Equity return is now at value 11.77, with 6.45 for asset returns.
Based on Hologic, Inc (HOLX), the company’s capital structure generated 0.35 points at debt to capital in total, while cash flow to debt ratio is standing at 0.45. The debt to equity ratio resting at 0.55. The interest coverage ratio of the stock is 5.81.
Currently, EBITDA for the company is 1.3 billion with net debt to EBITDA at 1.08. When we switch over and look at the enterprise to sales, we see a ratio of 3.76. The receivables turnover for the company is 6.25for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.24.
Conclusion
In summary, Hologic, Inc (HOLX) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
